KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $57.6 million.

  • Idexx Laboratories' Other Non-Current Liabilities fell 836.21% to $57.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.6 million, marking a year-over-year decrease of 836.21%. This contributed to the annual value of $44.3 million for FY2024, which is 3233.07% down from last year.
  • Per Idexx Laboratories' latest filing, its Other Non-Current Liabilities stood at $57.6 million for Q3 2025, which was down 836.21% from $56.8 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Other Non-Current Liabilities high stood at $85.0 million for Q2 2021, and its period low was $44.3 million during Q4 2024.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $66.3 million (2024), whereas its average is $65.4 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 3233.07% in 2024, then skyrocketed by 635.25% in 2025.
  • Over the past 5 years, Idexx Laboratories' Other Non-Current Liabilities (Quarter) stood at $70.9 million in 2021, then decreased by 4.73% to $67.6 million in 2022, then dropped by 3.05% to $65.5 million in 2023, then crashed by 32.33% to $44.3 million in 2024, then rose by 29.95% to $57.6 million in 2025.
  • Its last three reported values are $57.6 million in Q3 2025, $56.8 million for Q2 2025, and $47.7 million during Q1 2025.